| Income Statement |
| Operating Expenses | -1.64M |
|
| Research and Development Expense | -312.00K |
| Selling, General and Administrative Expense | -1.29M |
| Operating Income | 1.64M |
| Net Income | -1.83M |
| Net Income Common Stock | -1.83M |
| Net Income Common Stock (USD) | -1.83M |
| Consolidated Income | -1.83M |
| Earnings per Basic Share | -0.29 |
| Earnings per Basic Share (USD) | -0.29 |
| Earnings per Diluted Share | -0.29 |
| Earning Before Interest & Taxes (EBIT) | -1.83M |
| Earning Before Interest & Taxes (USD) | -1.83M |
| Weighted Average Shares | 6.37M |
| Weighted Average Shares Diluted | 6.37M |
| Balance Sheet |
| Cash and Equivalents | 2.60M |
| Cash and Equivalents (USD) | 2.60M |
| Trade and Non-Trade Receivables | 60.00K |
| Current Assets | 3.53M |
| Property, Plant & Equipment Net | 219.00K |
| Total Assets | 12.76M |
| Current Liabilities | 4.46M |
| Total Liabilities | 10.66M |
| Accumulated Retained Earnings (Deficit) | -206.04M |
| Accumulated Other Comprehensive Income | -2.00K |
| Shareholders Equity | 2.10M |
| Shareholders Equity (USD) | 2.10M |
| Assets Non-Current | 9.22M |
| Goodwill and Intangible Assets | 8.18M |
| Liabilities Non-Current | 6.20M |
| Trade and Non-Trade Payables | 2.44M |
| Tax Liabilities | 423.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 106.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.14M |
| Net Cash Flow from Operations | -1.14M |